US 8779129
Triazinedione derivatives as GABAB receptor modulators
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8779129 (Triazinedione derivatives as GABAB receptor modulators) held by Addex Pharma, S.A. expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/14, A61P13/10